The ESCMID Study Group for Bloodstream Infections, Endocarditis, and Sepsis (ESGBIES) is committed to improving the management of bloodstream infections, infective endocarditis, and sepsis. This network of dedicated experts focuses on:
Through a strong dedication to research, ESGBIES drives forward to create educational initiatives, such as in-person seminars, courses, and webinars, as well as joint projects. Both longstanding and new members are appreciated for playing an invaluable role in this shared mission.
ESGBIES is happy to announce two ESGBIES AWARDS for 2025-2026:
Best Article Award
The ESGBIES Best Article Award aims to recognize outstanding collaborative research in Clinical Microbiology (CM) and Infectious Diseases (ID), co-authored by researchers from different countries. The award includes a monetary prize of 1,000 euros.
Application open: September 1st and September 15th, 2025
Best Abstract Award
The ESGBIES Best Abstract Award recognizes ESCMID Young Scientist Members who present their research at ESCMID Global. The award includes:
• 500 euros for the best abstract
• 300 euros for the second-best abstract
Application open: March 1st and March 15th
Interested?
Find out more about the eligibility criteria below
An Update on Recent Clinical Trial Data in Bloodstream Infection.
Stewart AG, Simos P, Sivabalan P, Escolà-Vergé L, Garnham K, Isler B; ESGBIES Study Group. Antibiotics (Basel). 2024 Nov 1;13(11):1035
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study).
Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D, Dell'Aquila A, Ripa M, Işık ME,Kızmaz YU, Iacopino S, Camici M, Perna F, Akinosoglou K, Karruli A, Papadimitriou-Olivgeris M, Kayaaslan B, Bilir YA, Evren Özcan E, Turan OE, Işık MC, Pérez- RodríguezMT, Yagüe BL, Quirós AM, Yılmaz M, Petersdorf S, De Potter T, Durante- Mangoni E, Akova M, Curnis A,Gibertoni D, Diemberger I, Scudeller L, Viale P, Giannella M, CarDINe Study Group. Int J Antimicrob Agents. 2023;61(3):106734.
Evidence for Short-Course Antimicrobial Treatment and Oral Step-Down Therapy in Gram-Negative Bloodstream Infections
12 November 2025 at 12:00 CET
Sepsis guidelines for better care: the French experience before and after ICU
04 June 2025 at 13:30 CET
Single-Site vs. Multi-Site Sampling Strategies: Tackling Blood Culture Contamination
12 March 2025, 13:00-14:00 CET
What is the best treatment for difficult-to-treat Pseudomonas aeruginosa infections/BSI?
15 January 2025, 13:00-14:00 CET
In which type of bloodstream infections follow-up blood cultures are needed?
11 December 2024
The best available therapy for BSI caused by MBL-producing Enterobacterales
26 June 2024
An echocardiography is needed in all patients with Enterococcus faecalis bacteraemia? PROS (Anders Dahl, Denmark) and CONS (Nuria Fernández-Hidalgo, Spain).
If you have questions or comments for our study group, we warmly invite you to contact us!